These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25896687)

  • 21. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.
    Marriott KA; Parkinson CV; Morefield SI; Davenport R; Nichols R; Monath TP
    Vaccine; 2008 Jan; 26(4):581-8. PubMed ID: 18077063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat.
    Hernandez LE; Jadoo A; Kirsner RS
    Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950
    [No Abstract]   [Full Text] [Related]  

  • 23. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox.
    Suzuki T; Saito S; Tsuzuki S; Ashida S; Takakusaki M; Yoshikawa T; Shimojima M; Ebihara H; Ohmagari N; Morioka S
    BMJ Open; 2023 Aug; 13(8):e069550. PubMed ID: 37527886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tecovirimat: First Global Approval.
    Hoy SM
    Drugs; 2018 Sep; 78(13):1377-1382. PubMed ID: 30120738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
    Chan-Tack KM; Harrington PR; Choi SY; Myers L; O'Rear J; Seo S; McMillan D; Ghantous H; Birnkrant D; Sherwat AI
    Lancet Infect Dis; 2019 Jun; 19(6):e221-e224. PubMed ID: 30853252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro efficacy of ST246 against smallpox and monkeypox.
    Smith SK; Olson VA; Karem KL; Jordan R; Hruby DE; Damon IK
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1007-12. PubMed ID: 19075062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
    Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH
    JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development and approval of tecoviromat (TPOXX
    Merchlinsky M; Albright A; Olson V; Schiltz H; Merkeley T; Hughes C; Petersen B; Challberg M
    Antiviral Res; 2019 Aug; 168():168-174. PubMed ID: 31181284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.
    Berhanu A; King DS; Mosier S; Jordan R; Jones KF; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4999-5009. PubMed ID: 19752270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies.
    Sudarmaji N; Kifli N; Hermansyah A; Yeoh SF; Goh BH; Ming LC
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.
    Smith SK; Self J; Weiss S; Carroll D; Braden Z; Regnery RL; Davidson W; Jordan R; Hruby DE; Damon IK
    J Virol; 2011 Sep; 85(17):9176-87. PubMed ID: 21697474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects.
    Das T; Nandy S; Ghosh A; Chandran D; Sharma AK; Dhama K; Dey A
    Int J Surg; 2023 May; 109(5):1528-1530. PubMed ID: 36974695
    [No Abstract]   [Full Text] [Related]  

  • 34. New effective chemically synthesized anti-smallpox compound NIOCH-14.
    Mazurkov OY; Kabanov AS; Shishkina LN; Sergeev AA; Skarnovich MO; Bormotov NI; Skarnovich MA; Ovchinnikova AS; Titova KA; Galahova DO; Bulychev LE; Sergeev AA; Taranov OS; Selivanov BA; Tikhonov AY; Zavjalov EL; Agafonov AP; Sergeev AN
    J Gen Virol; 2016 May; 97(5):1229-1239. PubMed ID: 26861777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge.
    Parker S; D'Angelo J; Buller RM; Smee DF; Lantto J; Nielsen H; Jensen A; Prichard M; George SL
    Antiviral Res; 2021 Nov; 195():105179. PubMed ID: 34530009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection.
    Sbrana E; Jordan R; Hruby DE; Mateo RI; Xiao SY; Siirin M; Newman PC; DA Rosa AP; Tesh RB
    Am J Trop Med Hyg; 2007 Apr; 76(4):768-73. PubMed ID: 17426185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak.
    Turner M; Mandia J; Keltner C; Haynes R; Faestel P; Mease L
    Emerg Infect Dis; 2022 Nov; 28(11):2336-2338. PubMed ID: 36104166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
    Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
    Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMVAMUNE
    Keckler MS; Salzer JS; Patel N; Townsend MB; Nakazawa YJ; Doty JB; Gallardo-Romero NF; Satheshkumar PS; Carroll DS; Karem KL; Damon IK
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32698399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.